Drug
LP 003
LP 003: highest development phase Phase 2, developed by Longbio Pharma (Suzhou) Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Longbio Pharma (Suzhou) Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| LP-003 Injection NCT07785063 | Phase 2 | Peanut Allergies |
Latest
No recent events.
Follow LP 003 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.